Selected Publications

Ho SB, Monto A, Peyton A, Kaplan DE, Byrne S, Moon S, Copans A, Rossaro L, Roy A, Le H, Dvory-Sobol H, Zhu Y, Brainard DM, Guyer W, Shaikh O, Fuchs M, Morgan TR; VALOR study team: Efficacy of Sofosbuvir plus Ribavirin in veterans with hepatitis C virus genotype 2 infection, compensated cirrhosis, and multiple comorbidities. Clinical Gastroenterology & Hepatology 15(2): 282-288, Feb. 2017 Notes: (Epub May 27, 2016).

Essrani R, Hickey P, Peyton A, Shah H: Denture misadventure: The tooth about your colon. American Journal of Gastroenterology 112(Suppl 1): S1532, 2017.

Sclair SN, Hernandez MD, Vance E, Gilinski D, Youtseff H, Toro M, Antoine M, Jeffers LJ, Peyton A: Sofosbuvir and Simeprevir combination therapy for HCV genotype 1 infection: Results of a single-center VA experience. Gastroenterology & Hepatology (NY) 12(8): 490-497, Aug. 2016.

Ho SB, Monto A, Peyton A, Kaplan DE, Byrne S, Moon S, Le H, Copans A, Rossaro L, Zhu Y, Brainard D, Guyer W, Shaikh O, Fuchs M, Morgan TR: Sofosbuvir plus ribavirin for 12 weeks in genotype 2 HCV compensated cirrhotic patients: A comparative analysis of VALOR-HCV SVR data to registration trials and real world cohorts. Gastroenterology 150(4 Suppl 1): S925, 2016.

Ho S, Monto A, Peyton A, Kaplan DE, Moon B, Zhu Y, Seyedkazemi S, Rossaro L, Brainard DM, Guyer W, Shaikh OS, Fuchs M, Morgan TR: Twelve weeks of Sofosbuvir plus Ribavirin is effective for treatment of genotype 2 HCV in difficult to treat US veterans with cirrhosis: Results of the VALOR-HCV Study. American Association for Study of Liver Diseases, San Francisco, CA Dec. 2015 Notes: Oral presentation.

Gutierrez JA, Carrion A, Bhamidimarri KR, Peyton AL: Reply. Liver Transplantation 21(10): 1330, Oct. 2015.

Bhamidimarri K, Czul F, Peyton A, Levy C, Hernandez M, Jeffers L, Roth D, Schiff E, O’Brien C, Martin P : Safety, efficacy and tolerability of half-dose sofosbuvir plus simeprevir in treatment of Hepatitis C in patients with end stage renal disease. Journal of Hepatology 63(3): 763-765, Sept. 2015 Notes: (Epub June 18, 2015) (Erratum in: J Hepatol 2015 Dec; 63[6]:1542).

Gutierrez J, Carrion A, Avalos D, O’Brien C, Martin P, Bhamidimarri K, Peyton A: Sofosbuvir and Simeprevir for treatment of hepatitis C virus infection in liver transplant recipients. Liver Transplantation 21(6): 823-830, June 2015.

Avalos D, Schweitzer M, Peyton A, Bhamidimarri K, Gutierrez J : Insurance approval patterns for IFN-free regimens in HCV: Impact of national guidelines. Digestive Disease Week, Washington, DC May 2015 Notes: Oral presentation.

Sclair S, Peyton A, Youtseff H, Vance E, Hernandez M, Jeffers L: Comparative cost-effectiveness of Sofosbuvir regimens for treatment of HCV genotype 1 at a single VA hepatology practice. Digestive Disease Week, Washington, DC May 2015 Notes: Oral presentation.